Reference : USE OF COX-2 INHIBITORS FOR PREVENTING IMMUNODEFICIENCY
Patent : Patent
Human health sciences : Immunology & infectious disease
http://hdl.handle.net/2268/74454
USE OF COX-2 INHIBITORS FOR PREVENTING IMMUNODEFICIENCY
English
TASKÉN, Kjetil [> >]
Moutschen, Michel mailto [Université de Liège - ULg > > Maladies infectieuses et médecine interne générale >]
Rahmouni, Souad mailto [Université de Liège - ULg > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén. >]
Aandahl, Einar Martin [> >]
AUKRUST, Pål [> >]
FRØLAND, Stig, S [> >]
JOHANSSON, Christian, Carl [> >]
HANSSON, Vidar [> >]
KLAVENESS, Jo [> >]
31-Jan-2002
2001-07-20
World Intellectual Property Organization
WO/2002/007721
017908.5 GB 20.07.2000 and 0109648.6 GB 19.04.2001
A
GB
LAURAS AS, TASKÉN K, MOUTSCHEN M, RAHMOUNI-PIETTE S, AANDAHL E.M, UKRUST P, FRØLAND S.S, JOHANSSON C.C, HANSSON V, KLAVENESS J, ONES E.L.
A61K 31/18 (2006.01), A61K 31/365 (2006.01), A61K 31/381 (2006.01), A61K 31/405 (2006.01), A61K 31/407 (2006.01), A61K 31/415 (2006.01), A61K 31/5415 (2006.01), A61K 31/675 (2006.01)
PCT/GB2001/003284
AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW . (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW. (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM). (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR). (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR
[en] The present invention provides a method for treating or preventing a disorder typified by an immunodificiency (e.g. HIV), wherein the patient is administered a COX-2 inhibitor or derivative or pharmaceutically acceptable salt thereof, preferably diisopropylfluorophasphaate, L-745337, rofecoxi, NS 398, SC 58125, etodolac, meloxicam, celecoxib flusolide or nimesulide, and compositions and products containing the same or use of the same in preparing medicaments and for treatment.
http://hdl.handle.net/2268/74454

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.